(1)
Dupilumab Improves Disease Control and Patient-Reported Outcomes in Adults With Atopic Dermatitis in Clinical Practice: Subgroup Analysis of Black African American Population from RELIEVE-AD. J of Skin 2024, 8 (1), s327. https://doi.org/10.25251/skin.8.supp.327.